Not checked for notices yet.
Phase 2 study of everolimus for relapsed or refractory classical Hodgkin lymphoma
Patrick B. Johnston, Lauren C. Pinter-Brown, Ghulam Warsi and 2 more
Experimental Hematology & Oncology · 2018
Cited by papers we hold 1
- Targeting mTOR for cancer therapy · 2019No notice
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.